Abstract
Topics highlighted at the XVI International AIDS Conference in Toronto included HIV/AIDS vaccine research, entry inhibitors, integrase inhibitors, new NNRTIs and PIs, single-agent therapies, pre-exposure prophylaxis and microbicides. Beside the large scientific part, policy and funding were of great concern. Within this article we are trying to focus on topics with direct clinical relevance. This includes new epidemiological and resistance data, results from current studies investigating established and novel antiretroviral drugs and drug classes as well as new findings in therapy management and strategies.
Similar content being viewed by others
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Jülg, B., Goebel, F.D. Clinical News from the XVI International AIDS Conference: The Attempt of a Summing up. Infection 34, 294–297 (2006). https://doi.org/10.1007/s15010-006-6506-5
Issue Date:
DOI: https://doi.org/10.1007/s15010-006-6506-5